- Home
- OLO vs COLL Comparison
OLO vs COLL Comparison
Compare OLO & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLO
- COLL
- Stock Information
- Founded
- OLO 2005
- COLL 2002
- Country
- OLO United States
- COLL United States
- Employees
- OLO N/A
- COLL N/A
- Industry
- OLO Major Banks
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- OLO Finance
- COLL Health Care
- Exchange
- OLO Nasdaq
- COLL Nasdaq
- Market Cap
- OLO 1.1B
- COLL 910.2M
- IPO Year
- OLO 2021
- COLL 2015
- Fundamental
- Price
- OLO $6.12
- COLL $29.66
- Analyst Decision
- OLO Buy
- COLL Strong Buy
- Analyst Count
- OLO 3
- COLL 5
- Target Price
- OLO $8.67
- COLL $43.60
- AVG Volume (30 Days)
- OLO 1.2M
- COLL 456.4K
- Earning Date
- OLO 05-06-2025
- COLL 05-08-2025
- Dividend Yield
- OLO N/A
- COLL N/A
- EPS Growth
- OLO N/A
- COLL 43.56
- EPS
- OLO N/A
- COLL 1.86
- Revenue
- OLO $284,938,000.00
- COLL $631,449,000.00
- Revenue This Year
- OLO $17.50
- COLL $20.00
- Revenue Next Year
- OLO $18.43
- COLL $3.93
- P/E Ratio
- OLO N/A
- COLL $16.00
- Revenue Growth
- OLO 24.82
- COLL 11.41
- 52 Week Low
- OLO $4.20
- COLL $27.28
- 52 Week High
- OLO $8.35
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- OLO 35.25
- COLL 50.74
- Support Level
- OLO $5.96
- COLL $29.12
- Resistance Level
- OLO $6.58
- COLL $30.84
- Average True Range (ATR)
- OLO 0.18
- COLL 0.85
- MACD
- OLO -0.00
- COLL 0.06
- Stochastic Oscillator
- OLO 6.45
- COLL 58.06
Stock Price Comparison Chart: OLO vs COLL
About OLO Olo Inc.
Olo Inc is an open Software as a Service platform for restaurants. Its platform powers restaurant brands' on-demand digital commerce operations, enabling digital ordering, delivery, front-of-house management, and payments, while further strengthening and enhancing restaurants' direct guest relationships. The company generates revenue from providing its customers access to its platform.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.